Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk

Santosh D Bhosale1, Robert Moulder1,2, Tomi Suomi1,2

  • 1Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.

Iscience
|June 17, 2024
PubMed

Insights

Infant feeding choices and in-utero factors impact early development. Serum proteomics in mother-infant dyads revealed changes related to feeding and correlations with intestinal permeability, offering insights into childhood disease development.

Area of Science:

  • Pediatrics
  • Immunology
  • Biochemistry

Background:

  • Early life factors, including in-utero environment and diet, significantly influence child health and development.
  • Serum proteomics in infants can offer valuable insights into childhood diseases.
  • Perinatal and infant proteomes may reveal crucial biological perspectives.

Purpose of the Study:

  • To analyze serum proteomic differences between feeding groups in infants.
  • To identify changes in infant serum proteomes during the first year of life.
  • To explore correlations between infant feeding, perinatal factors, and intestinal permeability in a cohort at risk for type 1 diabetes.

Main Methods:

  • Serum samples from mother-infant dyads (n=22) at multiple time points (third trimester, delivery, postpartum, cord blood, and infant ages 3-12 months) were analyzed.
  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was employed for serum proteomics.
  • Correlations between protein intensities within dyads and with intestinal permeability data were assessed.

Main Results:

  • Proteomic profiles showed distinct changes related to infant feeding (extensively hydrolyzed vs. regular cow's milk formula) and age.
  • Significant correlations were observed between serum protein levels within mother-infant dyads.
  • Several protein correlations were significantly associated with intestinal permeability measurements.

Conclusions:

  • Serum proteomics can track developmental changes influenced by infant feeding and perinatal factors.
  • The identified proteomic signatures may provide biomarkers for early childhood health and disease risk.
  • Further research into the link between infant gut health, diet, and proteomic profiles is warranted.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
919
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K